Cardiology APP Fellowship Grand Rounds
SGLT2 Inhibitors and GLP1 Agonists in CV Disease

Learning Objectives - Upon conclusion of this activity, participants should be able to:

1. Recall cardiovascular indications and contraindications for use of SGLT2i and GLP1a.
2. Name the mechanism of action, side effects, and monitoring parameters for SGLT2i and GLP1a. 
3. Apply knowledge of SGLT2i and GLP1a into cardiovascular case study.

Date: 2/27/2023
Time: 3-4pm AZ time
Location: Online, via Zoom
Speaker: Angela Coulter, PharmD, BCACP

ATTENDANCE / CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance. All learners are encouraged to text attendance regardless of credit needs. This number is only used for receiving text messages related to tracking attendance. Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.